ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society

Cites (789)

Items 601–788 of 788

1. Herceptin Raises Its Sights Beyond Advanced Breast Cancer
   C. McNeil · 1998 · JNCI Journal of the National Cancer Institute
2. Pulmonary Effect of Amiodarone in Patients With Heart Failure
   Steven N Singh, Susan Gross Fisher, PRAKASH C. DEEDWANIA, Prashant Kumar Rohatgi, Bramah N. Singh, Ross D. Fletcher · 1997 · Journal of the American College of Cardiology
3. Effect of Diuretic-Based Antihypertensive Treatment on Cardiovascular Disease Risk in Older Diabetic Patients with Isolated Systolic Hypertension
   J. David Curb, Sara Pressel, Jeffrey A. Cutler, Peter J. Savage, William B. Applegate, Henry Richard Black, Greta H. Camel, BARRY R. DAVID, PHILLIP H. FROST, Nelly Mercedes Gonzalez et al. · 1997 · Survey of Anesthesiology
4. Recurrent remodeling after ventricular assistance: is long-term myocardial recovery attainable?
   David N Helman, Simon W. Maybaum, David L.S. Morales, Mathew Russell Williams, Ainat Beniaminovitz, Niloo M. Edwards, DONNA M. MANCINI, Mehmet C. Öz · 2000 · The Annals of Thoracic Surgery
5. Angiotensin-converting-enzyme inhibition in stable coronary artery disease
   The PEACE Trial Investigators · 2005 · ACC Current Journal Review
6. The LIDO, HOPE, MOXCON and WASH Studies
   Christopher G. Jones, John G.F. Cleland · 1999 · European Journal of Heart Failure
7. Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial
   Stuart D. Russell, Paulina Selaru, David Albert Pyne, Maha M Ghazzi, Kenneth Massey, Milton L. Pressler, Alexis Serikoff, Andrew J.S. Coats · 2003 · American Heart Journal
8. Angiotensin‐converting enzyme inhibition and physical training in heart failure
   Theo E. Meyer, Barbara Casadei, Andrew J.S. Coats, Patrick P. Davey, Stamatis N. Adamopoulos, A. RADAELLI, James Conway · 1991 · Journal of Internal Medicine
9. Doxorubicin/taxane combinations: cardiac toxicity and pharmacokinetics.
   J. A. Sparano · 1999 · PubMed
10. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy. A meta-analysis of randomized controlled trials
    Amar Desai, J.C. Fang, William H. Maisel, K. L. Baughman · 2005 · ACC Current Journal Review
11. CAPTOPRIL THERAPY FOR HEART FAILURE
    Alan J. Cowley, Karen Stainer, J M Rowley, J. R. Hampton · 1982 · The Lancet
12. Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure: Basis of a new physiologic approach to control of arrhythmia
    Milton Packer, Stephen S. Gottlieb, Paul Kessler · 1986 · The American Journal of Medicine
13. Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience
    Nuhad K. Ibrahim, Gabriel N. Hortobágyi, Michael S. Ewer, Mohammed Kumail Ali, Lina Asmar, Richard L. Theriault, Giuseppe Fraschini, Debra K. Frye, Aman U. Buzdar · 1999 · Cancer Chemotherapy and Pharmacology
14. Outpatient dobutamine for end-stage congestive heart failure
    Leslie W. Miller, ELIZABETH J. MERKLE, Virginia M. Herrmann · 1990 · Critical Care Medicine
15. Nonselective β-Adrenergic Blockade With Carvedilol Does Not Hinder the Benefits of Exercise Training in Patients With Congestive Heart Failure
    Laura A. Demopoulos, Michael Yeh, Marco Gentilucci, Marco Testa, Rachel Bijou, Stuart D. Katz, DONNA M. MANCINI, Margaret Jones, Thierry H. LeJemtel · 1997 · Circulation
16. Diagnosing Diastolic Heart Failure
    Dave J. W. Van Kraaij, Petra E.J. van Pol, A. W. Ruiters, J.B.R.M. de Swart, Daniel J. Lips, Nicole H.M.K. Uszko‐Lencer, Pieter A. Doevendans · 2002 · European Journal of Heart Failure
17. Physical Training Alters the Pathogenesis of Pacing-Induced Heart Failure Through Endothelium-Mediated Mechanisms in Awake Dogs
    Jie Wang, Geng‐Hua Yi, Mathias Knecht, Bo-lin Cai, Sulli Poposkis, Milton Packer, Daniel Burkhoff · 1997 · Circulation
18. Thyroid Hormone Abnormalities in Heart Failure: Possibilities for Therapy
    Michèle A. Hamilton, Lynne Warner Stevenson · 1996 · Thyroid
19. Anemia is associated with worse symptoms, greater impairment in functional capacity, and a significant increase in mortality in patients with advanced heart failure
    Gregg C. Fonarow, Tamara B. Horwich, Michèle A. Hamilton, Jacob Borenstein · 2002 · Journal of the American College of Cardiology
20. Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction: Comparison With Doppler Velocity Recordings
    Pı̈erre Ambrosi, Christiane Oddoze, Gilbert Habib · 2002 · Circulation
21. Role of Oxidative Stress in Transition of Hypertrophy to Heart Failure
    A Dhalla · 1996 · Journal of the American College of Cardiology
22. Oral enoximone therapy in chronic heart failure: A placebo-controlled randomized trial
    Kenneth A. Narahara · 1991 · American Heart Journal
23. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea
    C. Mueller, A Scholer, Kirsten Laule-Kilian · 2004 · ACC Current Journal Review
24. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
    Gary S. Roubin, C Y Choong, Susan Devenish-Meares, N N Sadick, P. J. FLETCHER, David Thomas Kelly, P Harris · 1984 · Circulation
25. The effects of oral ibopamine in patients with mild heart failure — a double blind placebo controlled comparison to furosemide
    John O. Parker · 1993 · International Journal of Cardiology
26. Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failure.
    Kar Neng Lai, Fernand Mac–Moune Lai, Antony C.T. Leung, Chung Ping Ho, John Vallance‐Owen · 1987 · PubMed
27. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)
    Shelby D. Reed, Joëlle Y. Friedman, Eric J. Velazquez, Ari Gnanasakthy, Robert M. Califf, Kevin Alan Schulman · 2004 · American Heart Journal
28. Lone Hepatitis C Virus Myocarditis Responsive to Immunosuppressive Therapy
    Andrea Frustaci, Fiorella Calabrese, Cristina Chimenti, Maurizio Pieroni, Gaetano Thiene, Attilio Maseri · 2002 · CHEST Journal
29. Women and mexican Americans receive fewer cardiovascular drugs following myocardial infarction than men and non-hispanic whites: The Corpus Christi Heart Project, 1988–1990
    Harald Herholz, David Calvin Goff, David J. Ramsey, Frances A. Chan, Carmen Ortiz, Darwin R. Labarthe, Milton Z. Nichaman · 1996 · Journal of Clinical Epidemiology
30. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure
    Henry S. Loeb, Gary R. Johnson, Andrew Henrick, R H Smith, Jon Wilson, Rosemary Cremo, J. N. Cohn · 1993 · Circulation
31. Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline
    Rita Yn Tz Sung, Guoying Huang, Ming Kong Shing, Stephen Oppenheimer, Chi Kong Li, Chi Kong Li, Joseph T. F. Lau, M.P Yuen · 1997 · International Journal of Cardiology
32. Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation
    Masako Matsuda, Yusuke Matsuda, T. Yamagishi, T. Takahashi, Masahiko Haraguchi, T. Tada, Reizo Kusukawa · 1991 · Cardiovascular Research
33. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary: A Report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging)
    Smith, Sidney C., Jr. · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
34. Reducing Lengths of Stay in the Coronary Care Unit With a Practice Guideline for Patients With Congestive Heart Failure Insights From a Controlled Clinical Trial
    Scott R. Weingarten, Mary S. Riedinger, Laura Conner, B. Johnson, A. Gray Ellrodt · 1994 · Medical Care
35. Potassium-Related Cardiac Arrhythmias and Their Treatment
    Allan B. Schwartz · 1978 · Angiology
36. ‘Biological’ depression; because sleep fails?Based on: The Seventh Shorvon Memorial Lecture delivered at The National Hospital, Queen's Square, London, W.C. 1. on Thursday, 24 January 1985.
    Alex Harley Crisp · 1986 · Postgraduate Medical Journal
37. Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure
    Maarten P. van den Berg, Anton E. Tuinenburg, Dirk Jan van Veldhuisen, Pieter Jan de Kam, Harry J.G.M. Crijns · 1998 · International Journal of Cardiology
38. The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure
    John G.F. Cleland, G. GILLEN, Henry J. Dargie · 1988 · European Heart Journal
39. Enhanced External Counterpulsation as Treatment for Chronic Angina in Patients With Left Ventricular Dysfunction: A Report From the International EECP Patient Registry (IEPR)
    Ozlem Z. Soran, Elizabeth D. Kennard, Sheryl F. Kelsey, Richard Holubkov, John E. Strobeck, Arthur Michael Feldman · 2002 · Congestive Heart Failure
40. Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with doppler velocity recordings
    Emily Lubien, Anthony Nicholas DeMaria, K. Krishnaswamy · 2002 · ACC Current Journal Review
41. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction
    David W. Baker · 1994 · JAMA
42. Potential role of potassium as a determinant of morbidity and mortality in patients with systemic hypertension and congestive heart failure
    Milton Packer · 1990 · The American Journal of Cardiology
43. Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure
    Lon G. Sherman, Chang‐seng Liang, Selina Baumgardner, Yzhar Charuzi, Francis Chardo, Chung S. Kim · 1986 · Clinical Pharmacology & Therapeutics
44. Diuretic Efficacy of High Dose Furosemide in Severe Heart Failure: Bolus Injection Versus Continuous Infusion
    Dormans Tp · 1996 · Journal of the American College of Cardiology
45. Predictors and determinants of hospital length of stay in congestive heart failure in ten community hospitals.
    Edward F. Philbin, Thomas A. Rocco, Laura J. Lynch, Vicki A. Rogers, Paul Jenkins · 1997 · PubMed
46. Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension
    Kouki Watanabe, Michihito Sekiya, Takashi Tsuruoka, Junichi Funada, Hiroshi Kameoka, Masao Miyagawa, Katsuhiko Kohara · 1999 · Journal of Hypertension
47. Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure
    Anthony Hatzizacharias, Thomas K. Makris, Panagiota G. Krespi, Filippos K. Triposkiadis, Paraskevi Voyatzi, Nicholas Dalianis, Michael Kyriakidis · 1999 · American Heart Journal
48. Elderly patients with heart failure: a study of satisfaction with care and quality of life
    P. Candlish, P. Watts, S. Redman, Patricia Whyte, Julia M. LOWE · 1998 · International Journal for Quality in Health Care
49. Digoxin–Macrolide Drug Interaction
    Eric D Bizjak, Vincent F. Mauro · 1997 · Annals of Pharmacotherapy
50. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
    André Herchuelz, F. Derenne, Florin T. Deger, Michèle Juvent, Eric H. Van Ganse, Michel Staroukine, A Verniory, J.M. Boeynaems, J. Douchamps · 1989 · Journal of Pharmacology and Experimental Therapeutics
51. Congestive Heart Failure: Potential Role of Arginine Vasopressin Antagonists in the Therapy of Heart Failure
    Steven R. Goldsmith · 2002 · Congestive Heart Failure
52. Biventricular Pacing in Severe Heart Failure Patients Reverses Electromechanical Dyssynchronization from Apex to Base
    Jean‐François Toussaint, Thomas Lavergne, JACKY OLLITRAUT, C. Hignette, Jean-Marc Darondel, Barbara De Dieuleveult, Marc Froissart, Jean‐Yves Le Heuzey, Louis Guize, Michel Paillard · 2000 · Pacing and Clinical Electrophysiology
53. Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure
    Hideki Watanabe, Masaaki Kakihana, Sadanori Ohtsuka, Yasuro Sugishita · 1998 · Journal of the American College of Cardiology
54. The Role of Echocardiography in the Diagnosis and Management of Heart Failure
    Antonio Vitarelli, Susan Tiukinhoy, Silvia Di Luzio, Manuela Zampino, Mihai Gheorghiade · 2003 · Heart Failure Reviews
55. Angiotensin‐Converting Enzyme Inhibitor Use in Older Patients with Heart Failure and Renal Dysfunction
    Edward F. Philbin, Robert N. Santella, Thomas A. Rocco · 1999 · Journal of the American Geriatrics Society
56. Effect of exercise on acute myocardial infarction in rats
    Judith S. Hochman, BERNADINE P. HEALY · 1986 · Journal of the American College of Cardiology
57. The propionyl-l-carnitine hypothesis: An alternative approach to treating heart failure
    Roberto Ferrari, Federica De Giuli · 1997 · Journal of Cardiac Failure
58. Cardiac resynchronization therapy for congestive heart failure.
    Finlay Aleck McAlister, Justin Adrian Ezekowitz, Natasha Wiebe, Brian Hunter Rowe, Carol Spooner, Ellen T Crumley, Lisa Hartling, Padma Kaul, Graham Nichol, Terry Paul Klassen · 2004 · PubMed Central
59. Effectiveness of imazodan for treatment of chronic congestive heart failure
    A.David Goldberg, John M. Nicklas, Sidney Goldstein · 1991 · The American Journal of Cardiology
60. Heart failure in the general population of men – morbidity, risk factors and prognosis
    Lars Wilhelmsen, Annika Rosengren, Henry Eriksson · 2001 · Journal of Internal Medicine
61. Outcomes in heart failure patients with preserved ejection fraction mortality, readmission and functional decline
    G.L. Smith, Fredrick A. Masoudi, Viola Vaccarino, Martha J. Radford, H.M. Krumholz · 2003 · ACC Current Journal Review
62. The MUSTT Study: Evaluating Testing and Treatment
    Helmut Klein, Sven Reek · 2000 · Journal of Interventional Cardiac Electrophysiology
63. Preventive effects of carvedilol on nitrate tolerance—a randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol
    Hideki Watanabe, Masaaki Kakihana, Sadanori Ohtsuka, Yasuro Sugishita · 1998 · Journal of the American College of Cardiology
64. Effects of Diuretic Therapy on the Development of Tolerance to Nitroglycerin and Exercise Capacity in Patients With Chronic Stable Angina
    John D. Parker, Andrea B. Parker, Bernice Farrell, John O. Parker · 1996 · Circulation
65. A Comparison of Angioplasty With Medical Therapy in the Treatment of Single-Vessel Coronary Artery Disease
    Alfred F. Parisi, Edward D. Folland, Pamela M. Hartigan · 1992 · Journal of Cardiopulmonary Rehabilitation
66. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
    Donald S. Silverberg, Dov Wexler, S Sheps · 2001 · ACC Current Journal Review
67. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices - Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to update the 1998 Pacemaker Guidelines)
    Smith, Sidney C., Jr. · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
68. Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure
    Wilson S. Colucci, Edmund H. Sonnenblick, Kirkwood F. Adams, Martin R. Berk, Susan C. Brozena, Allan J. Cowley, J. M. Grabicki, Spencer A. Kubo, Thierry H. LeJemtel, William A. Littler et al. · 1993 · Journal of the American College of Cardiology
69. Congestive Heart Failure in Women: Focus on Heart Failure due to Coronary Artery Disease and Diabetes
    Carey D. Kimmelstiel, Robert Joel Goldberg · 2008 · Cardiology
70. The mid-term results of ventricular containment (ACORN WRAP) for end-stage ischemic cardiomyopathy.
    Jai Raman, Mitsumasa Hata, Meg Storer, J M Power, Brian F. Buxton, Clif A. Alferness, David L. Hare · 2001 · PubMed
71. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation effect of upgrading to biventricular pacing after chronic right ventricular pacing
    A.R. Leon, J.M. Greenberg, N. Kanuru · 2002 · ACC Current Journal Review
72. Investigation of α1‐adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries
    K. M. Smith, Joyce Macmillan, John Christie McGrath · 1997 · British Journal of Pharmacology
73. Enhanced external counterpulsation for the relief of angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes
    Georgiann C. Linnemeier, Martin K. Rutter, Gregory W. Barsness, Elizabeth D. Kennard, Richard W. Nesto · 2003 · American Heart Journal
74. Antithrombotic therapy in atrial fibrillation: A review of randomized trials with special reference to the stroke prevention in atrial fibrillation II (SPAF II) trial
    Kalyanam Shivkumar, Syed M. Jafri, Mihai Gheorghiade · 1996 · Progress in Cardiovascular Diseases
75. Drugs, Heart Failure and Quality of Life
    Nobutaka Doba, Hirofumi Tomiyama, Tsuyoshi Nakayama · 1999 · Drugs & Aging
76. Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure
    Robert J Cody, Kenneth W. Franklin, John H. Laragh · 1982 · American Heart Journal
77. Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
    Nancy Jeanne Brown, Diane Ryder, James V. Gainer, Jason D. Morrow, John Nadeau · 1996 · Journal of Pharmacology and Experimental Therapeutics
78. Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure.
    Barry M. Massie, B Krämer, Frances Haughom · 1981 · Circulation
79. Antihypertensive treatment in hypertensive patients with normal left ventricular mass is associated with left ventricular remodeling and improved diastolic function
    Douglas S. Schulman, Angel R. Flores, John F. Tugoen, SINDA B. DIANZUMBA, Nathaniel Reichek · 1996 · The American Journal of Cardiology
80. Rate or rhythm control in persistent atrial fibrillation?
    Christopher John Boos, JOERG CARLSSON, Ranjit S More · 2003 · QJM
81. Gender, age, and heart failure with preserved left ventricular systolic function
    F.A. Masoudi, Edward P. Havranek, G.L. Smith · 2003 · ACC Current Journal Review
82. Effect of conditioning and deconditioning stimuli on metabolically determined blood flow in humans and implications for congestive heart failure
    Lawrence I. Sinoway · 1988 · The American Journal of Cardiology
83. Comparative Pharmacokinetics and Pharmacodynamics of Loop Diuretics in Renal Failure
    T. Risler, A. Schwab, B. Kramer, N. Braun, C. Erley · 2008 · Cardiology
84. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial
    M Gheorghiade, Wendy A. Gattis, C.M O'Connor · 2004 · ACC Current Journal Review
85. Changes in quality of care for five diseases measured by implicit review, 1981 to 1986
    Lisa V. Rubenstein · 1990 · JAMA
86. Digoxin and increased mortality among patients recovering from acute myocardial infarction: Importance of digoxin dose
    Jonathan Leor, Uri Goldbourt, Babeth Rabinowitz, Henrietta Reicher-Reiss, Valentina Boyko, Elieser Kaplinsky, Solomon Behar, the SPRINT Study Group · 1995 · Cardiovascular Drugs and Therapy
87. Chronic AT1 receptor blockade and angiotensin-converting enzyme (ACE) inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival
    Natacha R. Bastien · 1999 · Cardiovascular Research
88. Renal response to Indomethacin in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
    Stephen S. Gottlieb, Shawn Robinson, Catherine M. Krichten, Michael L. Fisher · 1992 · The American Journal of Cardiology
89. Intermittent Venovenous Hemofiltration as a Chronic Treatment for Refractory and Intractable Heart Failure
    Stefano Biasioli, Franco Barbaresi, Mario Barbiero, Luigi Petrosino, Lucia Cavallini, Alberto Zambello, Carlos Augusto de Oliveira Cavalcanti, R. Foroni, C. BONOFICLIO · 1992 · ASAIO Journal
90. Hereditary dilated cardiomyopathy
    Thomas R. McMinn, John Ross · 1995 · Clinical Cardiology
91. Electrical and hemodynamic correlates of the maximal rate of pressure increase in the human left ventricle
    Ari G. Fried, Andrea B. Parker, Gary E. Newton, John D. Parker · 1999 · Journal of Cardiac Failure
92. The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies
    Maria Teresa Zanella, Artur Beltrame Ribeiro · 2002 · Clinical Therapeutics
93. Letters to the Editor
    K McDonald, B Maurer · 1998 · European Heart Journal
94. Use of angiotensin receptor antagonists in patients with ACE inhibitor induced angioedema
    Sabine A. Fuchs, Ronald H.B. Meyboom, Eugène van Puijenbroek, Henk‐Jan Guchelaar · 2004 · Pharmacy World & Science
95. A Randomized Comparison of Intravenous Amrinone Versus Dobutamine in Older Patients with Decompensated Congestive Heart Failure
    Michael W. Rich, William L. Woods, Víctor G. Dávila‐Román, Patrick J. Morello, Howard I. Kurz, Rick A. Barbarash, Lisa R. Spinner, Jane C. Sperry, Valerie Beckham, Lynn Coulter et al. · 1995 · Journal of the American Geriatrics Society
96. Use of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failure
    Kishore J. Harjai, Sergio Solis, Ananth Prasad, Jill Loupe · 2003 · International Journal of Cardiology
97. α1b‐Adrenoceptors mediate renal tubular sodium and water reabsorption in the rat
    A. M. Elhawary, C. C. Y. Pang · 1994 · British Journal of Pharmacology
98. Influence of Age on the Prognostic Importance of Left Ventricular Dysfunction and Congestive Heart Failure on Long-Term Survival After Acute Myocardial Infarction
    Lars Køber, Christian Tobias Torp-Pedersen, Michael Mundt Ottesen, Hans Burchardt, Eva Korup, Keld Lyngborg · 1996 · The American Journal of Cardiology
99. Pharmacotherapy of Type 2 Diabetes Mellitus
    Marc Rendell, William R. Kirchain · 2000 · Annals of Pharmacotherapy
100. Quality of care for elderly patients hospitalized with heart failure
     H. M. Krumholz · 1997 · Archives of Internal Medicine
101. Predictors of readmission among elderly survivors of admission with heart failure
     William L. Henrich, Harlan M. Krumholz, Ya-Ting M. Chen, Yun M. Wang, Viola Vaccarino, Martha J. Radford · 2000 · American Heart Journal
102. Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure
     Milton Packer, Wai Hung Lee, Norma Medina, Madeline Yushak, Paul Kessler, Stephen S. Gottlieb · 1987 · The American Journal of Medicine
103. Influence of isoproterenol on myocardial energetics. Experimental and clinical investigations
     Gerd P Hasenfuss, C Holubarsch, Edward M. Blanchard, L. A. Mulieri, Norman R. Alpert, Hj. Just · 1989 · Steinkopff eBooks
104. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
     David R. Glover, Christopher G Wathen, R. Gordon Murray, Michael C. Petch, A L Muir, William A. Littler · 1985 · Heart
105. Normalization of cardiac structure and function after regression of cardiac hypertrophy
     Gabriel B. Habib, Douglas L. Mann, William A. Zoghbi · 1994 · American Heart Journal
106. Effects of long-term treatment with angiotensin-converting enzyme inhibitors in the presence or absence of aspirin: A systematic review
     KC Teo, Salim Yusuf, Pfeffer Ma · 2003 · ACC Current Journal Review
107. Force-frequency relation in patients with left ventricular hypertrophy and failure
     David A. Kass · 1998 · Basic Research in Cardiology
108. Genomic medicine and atrial fibrillation**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
     Luisa Mestroni · 2003 · Journal of the American College of Cardiology
109. Cardiac Resynchronization Therapy for Congestive Heart Failure
     Nitish Badhwar, Byron Kwock Lee · 2007 · Springer eBooks
110. The role of implantable cardioverter defibrillators in dilated cardiomyopathy
     Martin Borggrefe, Xu Chen, Antoni Martínez‐Rubio, Gerhard Hindricks, Wilhelm Haverkamp, Michael S. Block, Günter Breithardt · 1994 · American Heart Journal
111. Calcium Antagonists in the Elderly
     Janice B. Schwartz · 1996 · Drugs & Aging
112. Antiarrhythmic Effect of Carvedilol After Acute Myocardial Infarction. Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) Trial
     J. McMurray, Lars Køber, M. Robertson · 2005 · ACC Current Journal Review
113. Lesser Response to Angiotensin-Converting-Enzyme Inhibitor Therapy in Black As Compared With White Patients With Left Ventricular Dysfunction
     Richard A. Wiklund · 2002 · Survey of Anesthesiology
114. Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction. Short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping
     K Soejima, M Suzuki, W.H Maisel · 2002 · ACC Current Journal Review
115. Incidence of digoxin toxicity in outpatients.
     John F. Steiner, Laurence J. Robbins, Karl E. Hammermeister, S Roth, William S. Hammond · 1994 · PubMed Central
116. Both β1- and β2-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human right atrium
     A. Kaumann, L. Sanders · 1993 · Naunyn-Schmiedeberg's Archives of Pharmacology
117. Rites and Responsibility for Resuscitation in Heart Failure
     Lynne Warner Stevenson · 1998 · Circulation
118. Influence of age on mechanisms and prognosis of heart failure
     C. Vincent Hughes, M Wong, Gary R. Johnson, J. N. Cohn · 1993 · Circulation
119. Local forearm vasodilation with intra-arterial administration of enalaprilat in humans
     Alan J. Bank, Spencer H. Kubo, Thomas S. Rector, Steven M. Heifetz, Randall E. Williams · 1991 · Clinical Pharmacology & Therapeutics
120. Influence of isoproterenol on myocardial energetics. Experimental and clinical investigations
     Gerd P Hasenfuss, C Holubarsch, Edward M. Blanchard, L. A. Mulieri, Norman R. Alpert, Hj. Just · 1989 · Basic Research in Cardiology
121. Congestive heart failure with normal left ventricular systolic function. Clinical approaches to the diagnosis and treatment of diastolic heart failure
     Ramachandran Srini Vasan · 1996 · Archives of Internal Medicine
122. On the Epidemiology of Heart Failure
     Herbert Viefhues · 1991 · Springer eBooks
123. Adverse Effects of Amiodarone
     Gerald V. Naccarelli, Robert L. Rinkenberger, ANNE HAMILTON DOUGHERTY, David M. Fitzgerald · 1989 · Drug Safety
124. Low Prevalence of Hepatitis C Virus Antibodies and RNA in Patients with Myocarditis and Dilated Cardiomyopathy
     Isabella M. Grumbach, Klaus H. Heermann, Hans Reiner Figulla · 1998 · Cardiology
125. Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation.
     Hans Erik Bøtker, P Toft, N. A. Klitgaard, E E Simonsen · 1991 · Heart
126. Acute hemodynamic effects of conivaptan, a dual V1A and V2 vasopressin receptor antagonist, in patients with advanced heart failure
     J.E. Udelson, W B Smith, G.H. Hendrix · 2002 · ACC Current Journal Review
127. The antianginal efficacy of isosorbide dinitrate therapy is maintained during diuretic treatment
     Bruce Alexander Sussex, Norm R.C. Campbell, Mahesh K Raju, Donald W. McKay · 1994 · Clinical Pharmacology & Therapeutics
128. Long-Acting Verapamil and Heart Failure
     S Mohindra · 1989 · JAMA
129. Age and left ventricular ejection fraction identify patients with advanced breast cancer at high risk for development of epirubicin-induced heart failure
     Bente Krogsgaard Schaadt, Henning Kelbæk · 1997 · Journal of Nuclear Cardiology
130. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy
     Tomás Berl, Lawrence G. Hunsicker, Julia Breyer Lewis · 2003 · ACC Current Journal Review
131. Congestive heart failure in diabetes with hypertension may be due to uncoupling of the atrial natriuretic peptide receptor-effector system in the kidney basolateral membrane
     Animesh Sahai, Pallab K. Ganguly · 1991 · American Heart Journal
132. Taxanes in combination with doxorubicin in the treatment of metastatic breast cancer.
     Veronique C Dieras · 1998 · PubMed
133. Daily hemofiltration in severe heart failure.
     Luigi Iorio, Roberto Simonelli, Remo Giuseppe Nacca, L S DeSanto · 1997 · PubMed
134. The acute effects of a single dopamine infusion in elderly patients with congestive cardiac failure.
     Thompson Gordon Robinson, Salah Gariballa, G.J. Fancourt, J Potter, Mark Castleden · 1994 · British Journal of Clinical Pharmacology
135. Effect of angiotensin converting enzyme inhibition in renovascular hypertension
     Michel Burnier, Bernard Waeber, Jürg Nussberger, Hans Rudolf Brunner · 1989 · Journal of Hypertension
136. Cardiac damage following therapeutic chest irradiation. Importance, evaluation and treatment.
     Alessandro Vallebona · 2000 · PubMed
137. Introduction to the history and development of skeletal muscle plasticity and its clinical application to cardiomyoplasty and skeletal muscle ventricle.
     George J. Magovern · 1991 · PubMed
138. Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure.
     BMassie, BKramer, FHaughom · 1981 · Circulation
139. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart failure diagnosis in a primary care randomized, controlled trial
     S.P. Wright, R.N. Doughty, A. Pearl · 2004 · ACC Current Journal Review
140. Inhibition by basic drugs of digoxin secretion into human bile
     A. Hedman · 1992 · European Journal of Clinical Pharmacology
141. Postinfarction Use of β-Blockers in Elderly Patients
     Wilbert S. Aronow · 1997 · Drugs & Aging
142. Effects of coadministration of aspirin or clopidogrel on exercise testing in patients with heart failure receiving angiotensin-converting enzyme inhibitors**The opinions and research contained herein are exclusively those of the authors and are not to be considered as official or reflecting the views of the Department of the Army, Department of the Air Force, or the Department of Defense.
     Steve Kindsvater, Kenneth M. Leclerc, John A. Ward · 2003 · The American Journal of Cardiology
143. Left Ventricular Thrombus and the Incidence of Thromboembolism in Patients with Congestive Heart Failure: Can Clinical Factors Identify Patients at Increased Risk?
     Stuart D. Katz · 1995 · European Journal of Cardiovascular Prevention & Rehabilitation
144. Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure.
     A Cadel, Bruno Brusoni, P Pirelli, Giuseppe Osculati, A Rovati, R Fanciulli, L. Carati, Franco Valagussa · 1986 · PubMed
145. Left ventricular thrombus and the incidence of thromboembolism in patients with congestive heart failure: can clinical factors identify patients at increased risk?
     Stuart D. Katz · 1995 · Journal of Cardiovascular Risk
146. HYPERTROPHIC AND RESTRICTIVE CARDIOMYOPATHIES THE ELDERLY
     Susan J. Zieman, Nicholas J. Fortuin · 1999 · Cardiology Clinics
147. Thromboembolism and Antithrombotic Therapy in Congestive Heart Failure
     W. Bruce Dunkman · 1995 · European Journal of Cardiovascular Prevention & Rehabilitation
148. Angiotensin II receptor antagonists for heart failure
     Allan D. Struthers · 1998 · Heart
149. Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure
     A.D. Flapan, Eleanor Davies, C. Waugh, Brent C. Williams, T.R.D. Shaw, Christopher R. W. Edwards · 1991 · European Heart Journal
150. Thromboembolism and antithrombotic therapy in congestive heart failure
     W. Bruce Dunkman · 1995 · Journal of Cardiovascular Risk
151. Hyperinsulinemia Induces Myocardial Infarctions and Arteriolar Medial Hypertrophy in Spontaneously Hypertensive Rats
     Reuven Zimlichman · 1997 · American Journal of Hypertension
152. Insulin induces medial hypertrophy of myocardial arterioles in rats
     Reuven Zimlichman, L. Zeidel, Dov Gefel, Jacob Barg, Clarissa Shahar, Yael Nakash, Zipora Matas, S. Gass, H. E. Eliahou · 1995 · American Journal of Hypertension
153. Cardiovascular factors influencing survival in dialysis patients.
     M A Alpert · 1996 · PubMed
154. Cardiomyopathies : clinical presentation, differential diagnosis, and management
     James A. Shaver · 1988 · Medical Entomology and Zoology
155. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the initiation management predischarge: process for assessment of carvedilol therapy in heart failure (impact-hf) trial
     2004 · ACC Current Journal Review
156. Exercise training after anterior Q wave myocardial infarction: Importance of regional left ventricular function and topography
     Ellen Collins Kushner · 1989 · Journal of the American College of Cardiology
157. Daily Hemofiltration in Severe Heart Failure
     Luigi Iorio · 1998 · The International Journal of Artificial Organs
158. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure
     W.H.W. Tang, J.P. Girod, M.J. Lee · 2004 · ACC Current Journal Review
159. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment
     2004 · ACC Current Journal Review
160. Reversal of Autonomic Derangements by Physical Training in Chronic Heart Failure Assessed by Heart Rate Variability
     Richard V. Milani, Andrew L. Ries, JONATHAN N. MYERS · 1996 · Journal of Cardiopulmonary Rehabilitation
161. Clinical and Neurohormonal Effects of Nicardipine Hydrochloride in Patients With Severe Chronic Heart Failure Receiving Angiotensin-Converting Enzyme Inhibitor Therapy
     Daniel Benatar, Veronica Hall, Srinivas Reddy, Mihai Gheorghiade · 1998 · American Journal of Therapeutics
162. Late breaking heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANION
     John R. Teerlink, Barry M. Massie · 2003 · Journal of Cardiac Failure
163. Mortality in the survival with ORal D-sotalol (SWORD) trial: Why did patients die?
     Craig M. Pratt, Alan John Camm, William Cooper, Peter L. Friedman, Daniel J. MacNeil, Kathleen M. Moulton, Bertram Pitt, Peter J. Schwartz, Enrico P. Veltri, Albert L. Waldo · 1996 · Journal of the American College of Cardiology
164. Management of patients with heart failure and angina: Do coexistent diseases alter the response to cardiovascular drugs?
     Milton Packer, Marrick L. Kukin · 1991 · Journal of the American College of Cardiology
165. A nomogram for digoxin therapy
     1974 · The American Journal of Medicine
166. Lisinopril in the Treatment of Congestive Heart Failure in Elderly Patients: Comparison versus Captopril
     Carmine Morisco, Mario Condorelli, Gaetano Crepaldi, PAOLO RIZZON, Piero Zardini, Gianmarco Villa, Luigi Argenziano, Bruno Trimarco · 1997 · Cardiovascular Drugs and Therapy
167. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure
     Clyde W. Yancy, Michael B. Fowler, Wilson S. Colucci · 2001 · ACC Current Journal Review
168. Selection of patients for heart transplantation in the current era of heart failure therapy
     J Butler, Ghazanfar Khadim, K.M Paul · 2004 · ACC Current Journal Review
169. Diastolic Dysfunction as a Cause of Heart Failure
     James E. Udelson, Robert O. Bonow · 1993 · Hospital Practice
170. Diuretic treatment for the sodium retention of congestive heart failure
     R. J. Cody · 1994 · Archives of Internal Medicine
171. Prevention of heart failure
     Eugene S. Smith, Suzanne Trussell, Laura J. Mencer · 2002 · Current Opinion in Cardiology
172. Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure
     D.M McNamara, R Holubkov, Karen M. Janosko · 2001 · ACC Current Journal Review
173. Lack of Effect of Coenzyme Q on Left Ventricular Function in Patients with Congestive Heart Failure
     Paul S. Watson, Gregory Michael Scalia, Galbraith Aj, Darryl John Burstow, Nicholas Bett, Con N Aroney · 2000 · Journal of Cardiopulmonary Rehabilitation
174. Relationship between Right and Left-Sided Filling Pressures in 1000 Patients with Advanced Heart Failure.
     Mark H. Drazner, M A Hamilton, Gregg C. Fonarow, Julie W. Creaser, Carol M. Flavell, Stevenson L. Warner · 1999 · Cardiopulmonary Physical Therapy Journal
175. Cardiac toxicity of trastuzumab (herceptin): Implications for the design of adjuvant trials
     Joseph A. Sparano · 2001 · Seminars in Oncology
176. Lack of Effect of Coenzyme Q on Left Ventricular Function in Patients with Congestive Heart Failure
     &NA; · 1999 · Cardiology in Review
177. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: Complete recovery after restoration of sinus rhythm1
     Kevin G. Peters, M KIENZLE · 1988 · The American Journal of Medicine
178. Oral Anticoagulant Therapy at Elderly Age: Heart Failure and Nonvalvular Atrial Fibrillation.
     Nanette Kass Wenger · 1996 · PubMed
179. Experience From Controlled Trials of Physical Training in Chronic Heart Failure. Protocol and Patient Factors in Effectiveness in the Improvement in Exercise Tolerance.
     &NA; · 1998 · Journal of Cardiopulmonary Rehabilitation
180. From Left Ventricular Dysfunction to Heart Failure in the Elderly Patient.
     Rachel Bijou, Thierry H. Le Jemtel, Edmund H. Sonnenblick · 1993 · PubMed
181. Right and Left Ventricular Diastolic Function in Patients with and without Heart Failure: Effect of Age, Sex, Heart Rate, and Respiration on Doppler-Derived Measurements
     1997 · Journal of diagnostic medical sonography
182. Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillation in Advanced Chronic Heart Failure
     James B. Young · 2003 · JAMA
183. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. preventive services task force
     Cynthia D. Morris, S. Carson · 2003 · ACC Current Journal Review
184. Age and left ventricular ejection fraction identify patients with advanced breast cancer at high risk of development of epirubicin induced heart failure
     B SCHAADT, H Kelbœk · 1997 · Journal of Nuclear Cardiology
185. 24th Bethesda Conference: Cardiac Transplantation. Task Force 3: Recipient Guidelines/Prioritization
     Mudge, Gilbert H., Goldstein, Sidney, Addonizio, Linda J., Arthur L. Caplan · 1993 · DigitalGeorgetown (Georgetown University Library)
186. Clinical benefits of low serum digoxin concentrations in heart failure
     Todd A. Schwartz, Mihai Gheorghiade, Kirkwood F. Adams, Barry F. Uretsky, James Herbert Patterson, James B. Young · 2021 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
187. The Acute Effects of a Single Dopamine Infusion in Elderly Patients with Congestive Cardiac Failure
     Thompson Gordon Robinson, Salah Gariballa, G.J. Fancourt, J. POTTER, Mark Castleden · 1995 · Survey of Anesthesiology
188. Resuscitation Preferences Among Patients With Severe Congestive Heart Failure: Results From the SUPPORT Project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments
     Harlan M. Krumholz, R R Phillips, Mary Beth Hamel, Teno, Joan M., Bellamy, Paul, Steven K. Broste, Robert M. Califf, Humberto J. Vidaillet Jr., Davis, Roger B., Muhlbaier, Lawrence H. et al. · 1998 · DigitalGeorgetown (Georgetown University Library)